UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006604
Receipt No. R000007812
Scientific Title Phase I/II study to evaluate the efficacy and safety of the combination treatment of melpharan, dexamethasone and bortezomib for relapsed or refractory systemic AL amyloidosis.
Date of disclosure of the study information 2011/10/24
Last modified on 2015/04/29 15:01:05

No. Disposal Last modified on Item of update
1 Insert 2011/10/24 18:52:15
2 Update 2012/12/19 17:09:12 Interventions/Control_1
Interventions/Control_1
Key exclusion criteria
Key exclusion criteria
3 Update 2013/05/29 17:55:16 Key exclusion criteria
Key exclusion criteria
4 Update 2013/05/29 17:58:19 Institutions
5 Update 2013/12/17 19:19:30 Interventions/Control_1
Interventions/Control_1
6 Update 2013/12/17 19:26:56 TEL
Email
Address
7 Update 2014/05/20 10:34:24 Organization
Organization
Organization
Organization
Institute
Institute
Organization1
Institutions
8 Update 2015/04/29 15:01:05 Recruitment status
Date trial data considered complete


Contact us.